This track focuses on the latest advancements in diabetes management, including novel therapeutic strategies and patient-centered care approaches. Participants will explore cutting-edge technologies and their implications for improving patient outcomes.

This session addresses the unique challenges faced in the management of pediatric diabetes, including Type 1 and Type 2 diabetes. Experts will discuss innovative treatment options and strategies for enhancing the quality of care for children.

This track examines the complexities of gestational diabetes, including risk factors, prevention strategies, and effective treatment modalities. Attendees will gain insights into optimizing maternal and fetal health outcomes.

This session highlights the critical role of dietary management and lifestyle interventions in diabetes prevention and control. Experts will share evidence-based strategies for promoting physical activity and healthy eating.

This track delves into the various complications associated with diabetes, including cardiovascular, renal, and neurological issues. Participants will discuss diagnostic approaches and management strategies to mitigate these complications.

This session focuses on endocrinology's role in diabetes care, emphasizing patient-oriented case management discussions. Attendees will engage in collaborative learning to enhance clinical practice.

This track explores the integration of advanced technologies, such as continuous glucose monitoring and insulin delivery systems, in diabetes treatment. Participants will evaluate the impact of these innovations on patient adherence and outcomes.

This session addresses the latest advancements in drug discovery and biomarker development for diabetes treatment. Researchers will present their findings on potential therapeutic targets and novel pharmacological agents.

This track focuses on the application of computational methods and data analytics in diabetes research. Participants will explore how these approaches can enhance understanding and management of diabetes.

This session examines the regulatory frameworks and economic considerations impacting diabetes research and treatment. Experts will discuss the implications of policy changes on clinical practice and research funding.

This track investigates the intersection of infectious diseases and diabetes, exploring how diabetes affects susceptibility to infections and vice versa. Participants will discuss global health strategies to address these intertwined challenges.